The United States Patent and Trademark Office (USPTO) has published a notice in the Federal Register announcing a modification to its COVID-19 Prioritized Examination Pilot Program. Read more
On August 4, 2021, the Department of Commerce filed for federal registration of the USPTO marks in an effort to protect trademark customers from misleading solicitations and trademark filing scams. Read more
On June 29, as a result of the recent Supreme Court decision in U.S. v. Arthrex, Inc., the United States Patent and Trademark Office (USPTO) implemented an interim procedure whereby review of a Patent Trial and Appeal Board (PTAB) final written decision in an inter partes, post-grant, or covered business method review may be initiated sua sponte by the Director or requested by a party to a PTAB proceeding. Read more
On June 29, as a result of the recent Supreme Court decision in U.S. v. Arthrex, Inc., the USPTO implemented an interim procedure whereby review of a Patent Trial and Appeal Board (PTAB) final written decision in an inter partes, post-grant, or covered business method review may be initiated sua sponte by the Director or requested by a party to a PTAB proceeding. Read more
The USPTO is seeking comments from the public regarding the impact of patent eligibility jurisprudence in the United States since the Supreme Court’s 2016 decisions in Mayo and Alice and subsequent Federal Circuit decisions applying the Supreme Court’s legal framework. Read more
On May 18, the USPTO published a Notice of Proposed Rulemaking (NPRM) to implement changes to trademark rules of practice authorized by the Trademark Modernization Act (TMA) of 2020. Read more
On May 18, the USPTO published a Notice of Proposed Rulemaking (NPRM) to implement changes to trademark rules of practice authorized by the Trademark Modernization Act (TMA) of 2020. Read more